DIVIS LABORATORIES has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Sep-18* | 3 Jun-19* | 3 Sep-19* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 12,850 | 11,399 | 14,456 | 26.8% | 12.5% |
Other income | Rs m | 801 | 316 | 470 | 48.7% | -41.2% |
Turnover | Rs m | 13,651 | 11,716 | 14,926 | 27.4% | 9.3% |
Expenses | Rs m | 7,709 | 7,613 | 9,550 | 25.4% | 23.9% |
Gross profit | Rs m | 5,141 | 3,786 | 4,906 | 29.6% | -4.6% |
Depreciation | Rs m | 424 | 438 | 459 | 4.8% | 8.4% |
Interest | Rs m | 2 | 3 | 38 | 1084.4% | 1479.2% |
Profit before tax | Rs m | 5,516 | 3,661 | 4,879 | 33.3% | -11.5% |
Tax | Rs m | 1,539 | 988 | 1,311 | 32.7% | -14.8% |
Profit after tax | Rs m | 3,977 | 2,674 | 3,568 | 33.5% | -10.3% |
Gross profit margin | % | 40.0 | 33.2 | 33.9 | ||
Effective tax rate | % | 27.9 | 27.0 | 26.9 | ||
Net profit margin | % | 29.1 | 22.8 | 23.9 |
To see how DIVIS LABORATORIES has performed over the last eight quarters,please visit here.
Get Details: These 3 Stocks are the Dark Horses of the Stock Market
Over the last one year,DIVIS LABORATORIES share price has moved up from Rs 1,550.7 to Rs 1,708.0, registering a Gain of Rs 157.3 or around 10.1%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,125.3 (up 0.3%). Over the last one year it has moved down from 14,692.8 to 13,125.3, a gain of 1,567 points (down 10.7%).
Overall, the S&P BSE SENSEX is up 14.3% over the year.
At the current price of Rs 1,708.0, the price to earnings (P/E) ratio of DIVIS LABORATORIES stands at 35.1 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.5 times.
For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.
More Views on NewsMy new guide will show you the huge potential in future proof businesses.
The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
Ajit Dayal on the investing strategy for 2021 and beyond.
More
| |
Equitymaster requests your view! Post a comment on "DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!